Paul Knight
Stock Analyst at KeyBanc
(3.52)
# 2,263
Out of 5,022 analysts
263
Total ratings
44.6%
Success rate
4.7%
Average return
Main Sectors:
Stocks Rated by Paul Knight
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RVTY Revvity | Reiterated: Buy | $125 → $165 | $151.53 | +8.89% | 13 | Sep 4, 2026 | |
| LFCR Lifecore Biomedical | Reiterated: Hold | n/a | $6.54 | - | 4 | Aug 6, 2026 | |
| TKNO Alpha Teknova | Reiterated: Hold | n/a | $8.99 | - | 5 | Aug 6, 2026 | |
| WST West Pharmaceutical Services | Reiterated: Buy | $350 → $390 | $364.98 | +6.86% | 16 | Jul 2, 2026 | |
| CSTL Castle Biosciences | Reiterated: Buy | $50 → $35 | $35.60 | -1.69% | 9 | May 29, 2026 | |
| RPID Rapid Micro Biosystems | Reiterated: Buy | $8 → $5 | $0.92 | +443.48% | 3 | May 29, 2026 | |
| CYRX Cryoport | Reiterated: Buy | $15 → $17 | $17.43 | -2.47% | 10 | May 20, 2026 | |
| TECH Bio-Techne | Reiterated: Hold | n/a | $72.40 | - | 19 | May 7, 2026 | |
| XGN Exagen | Reiterated: Buy | $15 → $10 | $8.17 | +22.40% | 11 | Mar 11, 2026 | |
| STVN Stevanato Group | Rated: Buy | $37 → $32 | $20.20 | +58.42% | 7 | Mar 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.7447 | - | 9 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $220 | $181.70 | +21.08% | 13 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $310 | $214.06 | +44.82% | 9 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $750 | $654.80 | +14.54% | 9 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €415.00 → €320.00 | €251.40 | +27.29% | 2 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 | $37.30 | n/a | 10 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $220 | $119.91 | n/a | 2 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | CHF 525.00 | CHF 357.80 | n/a | 1 | Sep 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $167.78 | n/a | 12 | Aug 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $460 | $425.21 | n/a | 9 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $30 | $15.34 | n/a | 3 | Jun 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $7 → $30 | $8.34 | n/a | 9 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $27.52 | n/a | 2 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $132.55 | n/a | 3 | Feb 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | CHF 610.00 → CHF 635.00 | CHF 565.60 | n/a | 6 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $7.90 | n/a | 9 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $38.75 | n/a | 9 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $300 | $290.19 | n/a | 1 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $250 | $258.21 | n/a | 1 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.44 | n/a | 6 | Mar 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20 → $30 | $18.47 | n/a | 3 | Feb 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $6 → $2 | $0.0006 | n/a | 8 | Nov 26, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $4.94 | n/a | 2 | Jul 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $45.81 | n/a | 7 | Nov 29, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $273.04 | n/a | 6 | Oct 23, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $63.24 | n/a | 4 | Mar 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.12 | n/a | 2 | Mar 11, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $67.15 | n/a | 1 | Feb 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $75 → $85 | $232.99 | n/a | 2 | Jul 24, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $1.90 | n/a | 1 | May 5, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $61 → $46 | $12.15 | n/a | 2 | Dec 19, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $255 | $1,486.19 | n/a | 1 | Aug 15, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $24 | $44.75 | n/a | 1 | Aug 15, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $18 | $0.501 | n/a | 1 | Aug 15, 2013 |
Revvity
Sep 4, 2026
Reiterated: Buy
Price Target: $125 → $165
Current: $151.53
Upside: +8.89%
Lifecore Biomedical
Aug 6, 2026
Reiterated: Hold
Price Target: n/a
Current: $6.54
Upside: -
Alpha Teknova
Aug 6, 2026
Reiterated: Hold
Price Target: n/a
Current: $8.99
Upside: -
West Pharmaceutical Services
Jul 2, 2026
Reiterated: Buy
Price Target: $350 → $390
Current: $364.98
Upside: +6.86%
Castle Biosciences
May 29, 2026
Reiterated: Buy
Price Target: $50 → $35
Current: $35.60
Upside: -1.69%
Rapid Micro Biosystems
May 29, 2026
Reiterated: Buy
Price Target: $8 → $5
Current: $0.92
Upside: +443.48%
Cryoport
May 20, 2026
Reiterated: Buy
Price Target: $15 → $17
Current: $17.43
Upside: -2.47%
Bio-Techne
May 7, 2026
Reiterated: Hold
Price Target: n/a
Current: $72.40
Upside: -
Exagen
Mar 11, 2026
Reiterated: Buy
Price Target: $15 → $10
Current: $8.17
Upside: +22.40%
Stevanato Group
Mar 5, 2026
Rated: Buy
Price Target: $37 → $32
Current: $20.20
Upside: +58.42%
Feb 25, 2026
Reiterated: Hold
Price Target: n/a
Current: $0.7447
Upside: -
Feb 25, 2026
Reiterated: Buy
Price Target: $220
Current: $181.70
Upside: +21.08%
Dec 18, 2025
Rated: Buy
Price Target: $310
Current: $214.06
Upside: +44.82%
Dec 8, 2025
Upgraded: Buy
Price Target: $750
Current: $654.80
Upside: +14.54%
Oct 7, 2025
Reiterated: Buy
Price Target: €415.00 → €320.00
Current: €251.40
Upside: +27.29%
Oct 3, 2025
Reiterated: Buy
Price Target: $33
Current: $37.30
Upside: n/a
Sep 10, 2025
Reiterated: Buy
Price Target: $220
Current: $119.91
Upside: n/a
Sep 4, 2025
Initiated Coverage: Buy
Price Target: CHF 525.00
Current: CHF 357.80
Upside: n/a
Aug 28, 2025
Reiterated: Hold
Price Target: n/a
Current: $167.78
Upside: n/a
Aug 18, 2025
Reiterated: Buy
Price Target: $460
Current: $425.21
Upside: n/a
Jun 3, 2025
Reiterated: Buy
Price Target: $40 → $30
Current: $15.34
Upside: n/a
Apr 9, 2025
Downgraded: Hold
Price Target: $7 → $30
Current: $8.34
Upside: n/a
Mar 31, 2025
Downgraded: Hold
Price Target: n/a
Current: $27.52
Upside: n/a
Feb 5, 2025
Reiterated: Hold
Price Target: n/a
Current: $132.55
Upside: n/a
Jan 30, 2025
Reiterated: Buy
Price Target: CHF 610.00 → CHF 635.00
Current: CHF 565.60
Upside: n/a
May 9, 2024
Rated: Hold
Price Target: n/a
Current: $7.90
Upside: n/a
Nov 14, 2023
Rated: Hold
Price Target: n/a
Current: $38.75
Upside: n/a
May 5, 2022
Reiterated: Buy
Price Target: $300
Current: $290.19
Upside: n/a
Apr 28, 2022
Reiterated: Buy
Price Target: $250
Current: $258.21
Upside: n/a
Mar 14, 2022
Downgraded: Hold
Price Target: n/a
Current: $3.44
Upside: n/a
Feb 27, 2020
Reiterated: Hold
Price Target: $20 → $30
Current: $18.47
Upside: n/a
Nov 26, 2019
Downgraded: Hold
Price Target: $6 → $2
Current: $0.0006
Upside: n/a
Jul 24, 2019
Downgraded: Hold
Price Target: n/a
Current: $4.94
Upside: n/a
Nov 29, 2018
Downgraded: Hold
Price Target: n/a
Current: $45.81
Upside: n/a
Oct 23, 2017
Upgraded: Hold
Price Target: n/a
Current: $273.04
Upside: n/a
Mar 27, 2017
Downgraded: Hold
Price Target: n/a
Current: $63.24
Upside: n/a
Mar 11, 2016
Downgraded: Hold
Price Target: n/a
Current: $1.12
Upside: n/a
Feb 10, 2016
Initiated Coverage: Buy
Price Target: n/a
Current: $67.15
Upside: n/a
Jul 24, 2014
Downgraded: Hold
Price Target: $75 → $85
Current: $232.99
Upside: n/a
May 5, 2014
Upgraded: Buy
Price Target: n/a
Current: $1.90
Upside: n/a
Dec 19, 2013
Rated: Hold
Price Target: $61 → $46
Current: $12.15
Upside: n/a
Aug 15, 2013
Initiated Coverage: Hold
Price Target: $255
Current: $1,486.19
Upside: n/a
Aug 15, 2013
Initiated Coverage: Hold
Price Target: $24
Current: $44.75
Upside: n/a
Aug 15, 2013
Initiated Coverage: Hold
Price Target: $18
Current: $0.501
Upside: n/a